Kindbody raises $62 million

New York-based fertility and wellness startup Kindbody announced it raised $62 million in Series C funding. The round was led by Theresa Sexton, Managing Partner of Claritas Health Ventures, who now joins the Board of Directors, and includes new investment groups Bramalea Partners, Monashee Investment Management, and Eldridge, along with participating existing investors including GV (formerly Google Ventures), Perceptive Advisors, RRE Ventures, and Rock Springs Capital. To date, the company has raised $122 million.

Founded in 2018, Kindbody offers end-to-end services from preconception through postpartum, serving as both a provider and network solution. Its offering covers fertility treatment, including IVF and egg freezing, as well as gynecology, wellness, and LGBTQ+ services and its approach features direct purchasing and inclusive bundled-rates, which allows Kindbody to offer pricing up to 30% less than other fertility benefit programs.

“Kindbody’s revolutionary, high-demand model will drive meaningful change to the way fertility care is delivered in the US and abroad. The company’s vision for reducing barriers to care, expanding access, championing diversity, and delivering superior outcomes aligns directly with our mission at Claritas Health Ventures.” – Theresa Sexton, Managing Partner of Claritas Health Ventures.

“We’re grateful to have the support of Claritas and our new investors, who along with our existing investors, share our desire to expand access for all by completely reinventing the patient journey with technology and personalized care at affordable rates through every life stage. Creating change in healthcare is hard, time-consuming and expensive to do right. We are fortunate to have a committed group of investors who see the opportunity to disrupt a market in desperate need of innovation the way we do.” – Gina Bartasi, Founder of Kindbody.